In animal studies, there is strong experimental evidence that NAMPT (nicotinamide phosphoribosyltransferase), the key and rate-limiting enzyme in NAD+ biosynthesis, is down-regulated in obesity. This evidence concerns the gene NAMPT and obesity disorder.